Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference1%

- Check28 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.SummaryDifference0.2%

- Check43 days agoChange DetectedUpdated the page to Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' link was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated to version 3.0.1, which includes a new publication from PubMed regarding the safety of evobrutinib as a potential treatment for multiple sclerosis.SummaryDifference2%

- Check57 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across several countries, as well as the introduction of terms related to drug safety and counterfeit drugs. Notably, the previous version's references to certain locations and terms have been removed.SummaryDifference2%

- Check71 days agoChange DetectedThe web page has been updated to version 2.16.12, replacing the previous version 2.16.11. Additionally, a new section for 'Medical Information Location Map - Med Info Contacts' has been added.SummaryDifference0.2%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.